| Pierre Lammeretz |
Pierre Lammeretz currently works at Orgenesis, Inc., as Chief Operating Officer. |
| Victor Jay Miller |
Victor Jay Miller is currently a Director at COM DEV Investments Ltd. and holds the position of CFO, CAO, Secretary & Treasurer at Orgenesis, Inc. He previously worked as a Marketing Director at Baxter Healthcare Corp., a Director at COM DEV Ltd., a Director at COM DEV Europe Ltd. from 2016 to 2019, a Vice President-Leveraged Finance at Merrill Lynch & Co., Inc., a Vice President-Finance & Business Development at Neos Therapeutics, Inc., and a Senior Associate at Bankers Trust & Co. Mr. Miller obtained his undergraduate degree from The Wharton School of the University of Pennsylvania. |
| Elliot Maltz |
Currently, Elliot Maltz is Chief Financial Officer at Orgenesis, Inc.
In his past career he occupied the position of Treasurer, Chief Financial & Accounting Officer for Gelesis Holdings, Inc. and Chief Financial Officer & Treasurer for Gelesis, Inc. (a subsidiary of Gelesis Holdings, Inc.), Manager-Technical Accounting at Sapient Corp. and Auditor at Deloitte & Touche LLP.
Elliot Maltz received an undergraduate degree from Elon University. |
| Heiko von der Leyen |
Heiko von der Leyen is currently the Medical Director at Orgenesis, Inc. He previously worked as the Managing Director at Hannover Clinical Trial Center GmbH from 2005 to 2017. Prior to that, he was the Medical Director & VP-Clinical Development at Cardion GmbH from 1998 to 2001. He also served as the Chief Scientific Officer at Avontec GmbH in 2003 and at Artiss GmbH in 2001-2002. |
| Vered Caplan |
Vered Caplan is currently the Chairman, President & Chief Executive Officer at Orgenesis, Inc. and the Chief Executive Officer at Octomera LLC. She is also the Chairman at Orgenesis Biotech Israel Ltd. and a Director at Catalent Gosselies NV. Ms. Caplan previously served as the Chief Executive Officer at Gammacan International, Inc. from 2004 to 2007 and at Kamedis from 2009 to 2014. She was also a Director at MabCure, Inc. in 2012. Ms. Caplan has held various director positions at Retrieve Medical Holdings, Inc., Nehora Photonics Ltd., OptiCul Diagnostics Ltd., EVE Medical Systems Ltd., Her Justice, Inc., Ocure Ltd., Biotech Investment Corp., In Motion Ltd., and Catalent MSTC, Inc. Ms. Caplan received a graduate degree from Tel-Aviv University and an undergraduate degree from Technion-Israel Institute of Technology. |
| Sarah Ferber |
Sarah Ferber is the founder and the Chief Scientific Officer of Orgenesis, Inc., a company she founded in 2008. She holds degrees from Technion-Israel Institute of Technology (undergraduate, graduate, and doctorate), The University of Texas Southwestern Medical Center (undergraduate), and Harvard Medical School (doctorate). |
| Ashish Nanda |
Ashish Nanda is an Independent Director at Orgenesis, Inc., a Managing Director at Innovations Group, Inc., a Managing Partner at Capstone Insurance Brokers LLC, and a Managing Partner at Divetech Marine Engineering Services LLC. He previously worked as a Managing Director at The Innovations Group LLC and as an Assistant Manager-Corporate Banking at Emirates Banking Group from 1991 to 1994. |
| Claudia Zylberberg |
Claudia Zylberberg is the founder of Akron Bioproducts LLC, where she holds the title of Executive Chairman since 2006. Dr. Zylberberg is also the founder of AssureImmune LLC. Dr. Zylberberg's current jobs include being an Independent Director at Orgenesis, Inc. since 2023, a Director at BioFlorida, Inc., and a Director at the Centre For Commercialization of Regenerative Medicine. Dr. Zylberberg's former job was as Treasurer & Director at the Alliance for Regenerative Medicine. |
| Guy Yachin |
Guy Yachin was the founder of Chiasma, Inc. founded in 2001 where he served as Chief Executive Officer until 2007. He currently holds three positions as Chief Executive Officer at Oasis Management LLC since 2010, Independent Director at Orgenesis, Inc. since 2012, and Director at Exxel Pharma, Inc. since 2018. He has also served as a Director at several companies including Remon Medical Technologies, Inc., Retrieve Medical Holdings, Inc., NanoPass Technologies Ltd., Enzymotec Ltd., Thera-P Ltd., and Lartim Medical Ltd. Additionally, he was a Senior Consultant at Ofer Technologies Ltd. Mr. Yachin received his undergraduate degree in 1992 and his MBA in 1994 from Technion-Israel Institute of Technology. |
| Yaron Adler |
Yaron Adler is the founder of The We Group Ltd. (founded in 1999), Mircod LLC (founded in 2015), and Perion Network Ltd. (founded in 1999). Mr. Adler is currently the Chairman at Exitvalley Ltd. (since 2014), a Director at Inneractive Ltd., a Independent Director at Orgenesis, Inc. (since 2012), a Director at Typemock Ltd. (since 2014), and a Director at TriPlay, Inc. Mr. Adler has previously worked as a Director at eToro USA LLC and WhiteSmoke Israel Advanced Technologies Ltd. Mr. Adler was also a Product Manager at Tecnomatix Technologies Ltd. from 1994 to 1999. Mr. Adler received an undergraduate degree from Tel-Aviv University. |
| Mario Philips |
Mario Philips is currently the Chairman & Chief Executive Officer at Polyplus-transfection SA since 2023. He is also the Chief Executive Officer at Polyneuros SAS since 2019 and an Independent Director at Orgenesis, Inc. since 2020. In his former positions, Mr. Philips served as the Chairman at Clean Biologics. He was a Director at Artelis SA (Belgium) from 2007 to 2011 and at Eurofins Disposable Lab SASU from 2009 to 2019. He also held the position of Director at Austar Lifesciences Ltd. from 2007 to 2019. Additionally, he was a Senior Vice President at ATMI, Inc. from 2012 to 2013 and Vice President & General Manager at Danaher Corp. from 2014 to 2019. Mr. Philips was also the General Manager at ATMI LifeSciences from 2010 to 2014. Mr. Philips completed his undergraduate degree at Ghent University and his graduate degree at Groep T. |
| David Sidransky |
David Sidransky is the founder of Champions Oncology, Inc. (founded in 2008) and Israel Biotech Fund (founded in 2014), where he holds the titles of Lead Director and General Partner, respectively. He currently holds the position of Chairman at Old Ayala, Inc. (since 2019), Biosight Therapeutics, Inc. (since 2013), Ayala Pharmaceuticals, Inc. (since 2017), Rosetta Genomics Ltd. (since 2009), Orgenesis, Inc. (since 2013), The Sidney Kimmel Comprehensive Cancer Center (since 1994), Immune Pharmaceuticals, Inc., Galmed Pharmaceuticals Ltd. (since 2014), Ascentage Pharma Group International Co., Ltd. (since 2021), Biond Biologics Ltd., Exoprother Medical, The Johns Hopkins University (since 1998), American Society of Clinical Oncology, Inc., Biomerk, Inc., The Johns Hopkins University School of Medicine, and The American Association of Cancer Research. He has also held former positions as Chairman of Tamir Biotechnology, Inc. (2007-2020), Vice Chairman of ImClone LLC (2004-2008), Chairman of Old Ayala, Inc. (2017-2023), Independent Director of AMAG Pharma USA, Inc. (2012-2013), Director of AMAG Pharma USA, Inc. (2010-2012), Director of Zila, Inc. (2006-2007), Board of Director of Celsus Therapeutics Plc (2012-2015), Director of Advaxis, Inc. (2013-2015), Director of American Association for Cancer Research (2005-2008), Director of National Institute of Dental & Craniofacial Research, Director of Efranat Ltd., Director of Akari Therapeutics Plc, Director of Cardiff Oncology, Inc., Independent Director of Cactus Acquisition Corp. 1 Ltd., and Senior Editor of Clinical Cancer Research (2005-2008). Dr. Sidransky obtained his undergraduate degree from Brandeis University in 1981 and his doctorate degree from Baylor College of Medicine. |
